Observational studyJournal of clinical hypertension (Greenwich, Conn.)2014
Renal sympathetic denervation: early impact on ambulatory resistant hypertension.
Observational study in Journal of clinical hypertension (Greenwich, Conn.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Interactive effect between Selenium and Vitamin C levels on risk of hypertension among adult women in the United States: evidence from NHANES 2011 to 2020.Frontiers in nutrition · 2025Article
- Sacubitril/valsartan instead of renin-angiotensin system inhibition alone: A step forward in resistant hypertension.Journal of clinical hypertension (Greenwich, Conn.) · 2018Article
- Contributions to Hypertension Public Policy and Clinical Practice: A Review of Recent Reports.Journal of clinical hypertension (Greenwich, Conn.) · 2016Review
- Renal Denervation for the Treatment of Hypertension: Making a New Start, Getting It Right.Journal of clinical hypertension (Greenwich, Conn.) · 2015Article
- Renal Denervation for the Treatment of Hypertension: Making a New Start, Getting It Right.Clinical cardiology · 2015Article
- Renal denervation for the management of resistant hypertension.Integrated blood pressure control · 2015Review
- Renal nerve ablation for resistant hypertension: the dust has not yet settled.Journal of clinical hypertension (Greenwich, Conn.) · 2014Article
Corrections and comments
- Commented on by
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Although guidelines recommend ambulatory blood pressure (BP) monitoring (ABPM), few data are available regarding the effects of renal denervation (RDN) on 24-hour ABPM values. A total of 44 patients with mean systolic BP ≥135 mm Hg on ABPM despite adequate therapy were included. Basal systolic BP (SBP) and diastolic BP (DBP) were 154±11 mm Hg and 86±12 mm Hg, respectively. At 1 month, SBP and DBP were reduced to 146±18 mm Hg (P=.01) and 82±14 mm Hg and showed no further decrease up to 6 months. Only 55% of the patients responded to RDN (≥-5 mm Hg SBP), with a mean responder rate drop of 21/11 mm Hg. Neither the number of ablation points nor the amount of impedance drop was predictive of response. Only approximately half of patients with resistant hypertension responded to RDN. However, in these responders, a remarkable reduction of 24-hour BP occurred as early as 1 month after RDN.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.